← Scroll for more →
Financial Statements — BBNX
Balance Sheet
(in millions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 81.55 | 44.32 | 30.21 | 31.58 | 38.49 | 35.08 | 42.45 | 30.43 |
| Short-term Investments | 158.65 | 136.17 | 169.31 | 187.55 | 190.20 | 214.65 | 189.02 | 73.14 |
| Accounts Receivable | 20.67 | 18.05 | 15.75 | 17.12 | 11.54 | 11.40 | 9.06 | 12.00 |
| Inventory | 22.97 | 23.92 | 23.73 | 21.72 | 20.37 | 17.32 | 15.73 | 13.32 |
| Total Current Assets | 292.95 | 231.03 | 247.99 | 267.90 | 270.03 | 286.08 | 261.92 | 132.92 |
| Property, Plant & Equipment | 11.76 | 10.75 | 10.16 | 8.60 | 7.39 | 6.47 | 5.52 | 4.78 |
| Total Non-current Assets* | 150.81 | 61.35 | 56.43 | 60.84 | 60.02 | 43.90 | 76.11 | 16.72 |
| Total Assets | 443.76 | 292.39 | 304.42 | 328.74 | 330.05 | 329.97 | 338.02 | 149.65 |
| Accounts Payable | 4.68 | 5.35 | 2.32 | 5.00 | 4.46 | 3.42 | 3.45 | 2.85 |
| Total Current Liabilities | 32.84 | 26.02 | 23.19 | 30.92 | 25.39 | 19.49 | 16.49 | 21.15 |
| Total Non-current Liabilities* | 9.54 | 10.00 | 9.98 | 10.21 | 9.90 | 8.85 | 7.78 | 52.48 |
| Total Liabilities | 42.38 | 36.02 | 33.17 | 41.13 | 35.29 | 28.34 | 24.27 | 73.63 |
| Retained Earnings | (439.59) | (415.23) | (391.83) | (369.94) | (356.47) | (342.26) | (325.39) | (296.74) |
| Total Stockholder Equity | 401.38 | 256.37 | 271.25 | 287.61 | 294.76 | 301.63 | 313.75 | (245.36) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 35.51 | 32.01 | 27.63 | 32.12 | 27.25 | 23.24 | 17.64 | 20.44 |
| Cost of Revenue | 15.17 | 13.11 | 11.19 | 13.18 | 12.13 | 10.74 | 8.67 | 8.75 |
| Gross Profit | 20.33 | 18.90 | 16.44 | 18.94 | 15.12 | 12.50 | 8.97 | 11.69 |
| Research & Development | 11.98 | 10.24 | 10.36 | 10.13 | 8.20 | 8.87 | 7.59 | 9.21 |
| Selling, General & Admin | 9.84 | 9.60 | 9.62 | 8.60 | 7.92 | 7.88 | 6.62 | 4.71 |
| Total Operating Expenses | 46.94 | 44.48 | 40.71 | 35.07 | 32.16 | 32.38 | 27.61 | 24.73 |
| Operating Income | (26.61) | (25.58) | (24.27) | (16.12) | (17.04) | (19.87) | (18.64) | (13.04) |
| Net Income | (24.35) | (23.40) | (21.89) | (13.47) | (14.21) | (16.87) | (28.66) | (18.11) |
| Basic EPS | (0.52) | (0.53) | (0.49) | (0.16) | (0.33) | (0.39) | (0.93) | (2.70) |
| Diluted EPS | (0.52) | (0.53) | (0.49) | (0.16) | (0.33) | (0.39) | (0.93) | (2.70) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (12.29) | (14.62) | (23.83) | (8.63) | (8.73) | (13.59) | (19.98) |
| Capital Expenditures | 2.28 | 1.04 | 1.38 | 1.90 | 1.28 | 1.78 | 0.33 |
| Free Cash Flow* | (14.56) | (15.66) | (25.21) | (10.53) | (10.01) | (15.37) | (20.31) |
| Investing Cash Flow | (114.08) | 26.93 | 21.84 | 0.66 | 9.49 | 6.17 | (179.12) |
| Financing Cash Flow | 163.60 | 1.80 | 0.62 | 1.06 | 2.65 | 0.04 | 211.12 |
← Scroll for more columns →
* Derived from reported values